Chengdu Kanghua Biological Products Balance Sheet Health
Financial Health criteria checks 5/6
Chengdu Kanghua Biological Products has a total shareholder equity of CN¥3.5B and total debt of CN¥216.4M, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are CN¥4.0B and CN¥496.0M respectively. Chengdu Kanghua Biological Products's EBIT is CN¥674.6M making its interest coverage ratio -79.4. It has cash and short-term investments of CN¥762.3M.
Key information
6.3%
Debt to equity ratio
CN¥216.43m
Debt
| Interest coverage ratio | -79.4x |
| Cash | CN¥762.34m |
| Equity | CN¥3.45b |
| Total liabilities | CN¥496.01m |
| Total assets | CN¥3.95b |
Recent financial health updates
Recent updates
The Market Doesn't Like What It Sees From Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Earnings Yet
Sep 13
We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt
Jun 26Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares
Feb 27Financial Position Analysis
Short Term Liabilities: 300841's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥486.0M).
Long Term Liabilities: 300841's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥10.0M).
Debt to Equity History and Analysis
Debt Level: 300841 has more cash than its total debt.
Reducing Debt: 300841's debt to equity ratio has increased from 2.3% to 6.3% over the past 5 years.
Debt Coverage: 300841's debt is well covered by operating cash flow (259.6%).
Interest Coverage: 300841 earns more interest than it pays, so coverage of interest payments is not a concern.